同酶Q10与心脏骤停后轻度低温相结合:一项初步研究
Maxwell Simon Damian1, Diana Ellenberg, Ramona Gildemeister
1Department of Neurology, University Hospitals of Leicester, Leicester, United Kingdom. msd13@le.ac.uk
Circulation
|November 3, 2004
概括
在心肺复苏术 (CPR) 后将辅酶Q10 (CoQ10) 与治疗性低温症结合使用,显著改善了患者的生存率. 这种组合疗法也可以增强心脏骤停的幸存者的神经结果.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 生物化学 生物化学
背景情况:
- 治疗性低温是一种公认的方法,可以提高心肺复苏 (CPR) 后的生存率.
- 辅酶Q10 (CoQ10) 在各种神经退行性疾病中表现出神经保护性质.
- 在心脏骤停的幸存者中,将低温症与辅酶Q10结合在一起的潜在协同效应需要进行调查.
研究的目的:
- 评估在经过心肺复苏 (CPR) 的患者中将轻度低温与辅酶Q10 (CoQ10) 结合使用的疗效.
- 为了确定这种联合治疗是否与单独的低温相比,提供了额外的生存和神经系统益处.
主要方法:
- 一项随机对照试验,涉及49名患者在医院外心脏骤停后.
- 患者接受了轻度低温 (35°C24小时) 加CoQ10或低温加安慰剂.
- CoQ10 (250毫克,其次是150毫克三次每天5天) 或安慰剂通过鼻胃管进行.
主要成果:
- 与安慰剂组 (29%) 相比,CoQ10组 (68%) 的三个月存活率显著更高 (P=0.0413).
- 在辅酶Q10组中,更多的患者实现了有利的神经结果 (格拉斯哥结局量表4或5).
- 在CPR后24小时的平均血清S100蛋白水平在CoQ10组明显较低.
结论:
- 在心肺复苏后,辅酶Q10 (CoQ10) 与轻度低温症的结合似乎可以提高患者的存活率.
- 这种治疗策略也可能导致在心脏骤停后幸存下来的个体中改善神经恢复.
更多相关视频
相关概念视频
Ischemic Heart Disease: Overview
3.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495


